Zenith Drugs Ltd

Tue 22/09/2026,9:54:11 | NSE : ZENITHDRUG

₹42.000.00 (0.00%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 0.00

Previous Close

₹ 42.00

Volume

0

Mkt Cap ( ₹ Cr)

₹ 72.02

High

₹ 0.00

Low

₹ 0.00

52 Week High

₹ 73.45

52 Week Low

₹ 33.30

Book Value Per Share

₹ 43.69

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Zenith Drugs Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Zenith Drugs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Zenith Drugs - Copy of Newspaper Publication

    8 Sep 2026, 6:39PM Zenith Drugs Limited has informed the Exchange about Copy of Newspaper Publication
  • Zenith Drugs - Shareholders meeting

    5 Sep 2026, 1:14PM Zenith Drugs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026
  • Zenith Drugs - Outcome of Board Meeting

    5 Sep 2026, 1:07PM Zenith Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on September 05, 2026.
  • Zenith Drugs - Allotment of Securities

    26 Aug 2026, 1:50PM Zenith Drugs Limited has informed the Exchange regarding allotment of 1609050 share warrants pursuant to Preferential Issue at its meeting held on Aug
  • Zenith Drugs - Outcome of Board Meeting

    26 Aug 2026, 1:12PM Zenith Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on August 26, 2026.
  • Zenith Drugs - Outcome of Board Meeting

    26 Aug 2026, 1:10PM Zenith Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on August 26, 2026.
  • Zenith Drugs - Shareholders meeting

    25 Jul 2026, 3:24PM Zenith Drugs Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on July 23, 2026. Further, the compan
  • Zenith Drugs - Shareholders meeting

    23 Jul 2026, 3:55PM Zenith Drugs Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on July 23, 2026.
  • Zenith Drugs - Corrigendum

    10 Jul 2026, 7:10PM Zenith Drugs Limited has informed the Exchange regarding Corrigendum to Notice of Extra Ordinary General Meeting to be held on July 23, 2026
  • Zenith Drugs - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    10 Jul 2026, 7:01PM Zenith Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Zenith Drugs - Copy of Newspaper Publication

    1 Jul 2026, 3:43PM Zenith Drugs Limited has informed the Exchange about Copy of Newspaper Publication
  • Zenith Drugs - Shareholders meeting

    30 Jun 2026, 5:15PM Zenith Drugs Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on July 23, 2026
  • Zenith Drugs - Outcome of Board Meeting

    26 Jun 2026, 6:26PM Zenith Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 26, 2026.

Key fundamentals

Evaluate the intrinsic value of Zenith Drugs Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 130.0311 117.9472 86.1516 43.1509 29.6382
Liabilities 130.0311 117.9472 86.1516 43.1509 29.6382
Equity 17.1488 17.1488 17.1488 0.4 0.4
Gross Profit 12.1606 13.5785 16.9219 9.0501 6.9225
Net Profit 3.9426 7.1606 9.5369 4.8811 3.2129
Cash From Operating Activities 8.88 -5.4657 -12.4903 -4.2679 4.9081
NPM(%) 2.3 5.37 7.24 4.26 3.5
Revenue 171.2198 133.32 131.6197 114.5191 91.655
Expenses 159.0592 119.7415 114.6978 105.469 84.7325
ROE(%) 5.26 9.55 12.72 6.51 4.28

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
17 Sep 2024 0.5 5 0 67.75

Peers

Other companies within the same industry or sector that are comparable to Zenith Drugs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 845.35 0.43 21.38 0.00 -26.19 0.59
Lotus Eye Hospital and Institute Ltd 114.36 -0.28 1633.71 0.00 0.39 0.00
Vaishali Pharma Ltd 8.37 1.58 26.16 0.00 15.42 0.00
Astec Lifesciences Ltd 726.45 0.97 0.00 0.00 -363.14 0.00

Company Info

Our Company was originally incorporated on November 15, 2000 as a Private Limited Company in the name of "Zenith Drugs Private Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Madhya Pradesh, Gwalior. Subsequently pursuant to a Special Resolution of our Shareholders passed in the Extra-Ordinary General Meeting held on September 05, 2023, our Company was converted from a Private Limited Company to Public Limited Company and consequently, the name of our Company was changed to `Zenith Drugs Limited' and a Fresh Certificate of Incorporation consequent to Conversion was issued on September 13, 2023 by the Registrar of Companies, Gwalior.MAJOR EVENTS AND MILESTONES:2000-Incorporation of the Company.2001-Started as a manufacturing house for oral and external formulations.2004-Shifted to a Schedule M GMP compliant unit.-Started the production of two lines which are liquid orals and ointments.2007-Started manufacturing ORS Powder2016-Received WHO GMP certification2019-Turnover crossed 50 Crores.2020-Turnover crossed 75 Crores.2021-Certificate of Quality Management System ISO 9001:2015 issued by Global Grading Certification-Certificate of compliance with good manufacturing practices issued by Liberia Medicines and Health Products Regulatory Authority-Our Company received subsidy under Madhya Pradesh MSME Yojna i.e. MSME Promotion Scheme,2019 as Industrial Development Grant upto 40% of the capital invested in machinery i.e. grant of ? 170.04 Lakhs2022-The Company was recognized as among top 10 MSME Pharmaceutical Manufacturers in Indore in Industry Outlook Magazine Edition.2023-Turnover crossed 100 Crores.-Collaborated with Mr. Kshatriya Valtaprasad Nandkishore for Carrying out the task of Marketing and Export of the products manufactured by Zenith.-Conversion of our Company from Private Limited Company to Public Limited Company. 2024 -"Zenith Drugs has been awarded Tenders issued by the Uttar Pradesh Medical Supplies Corporation Limited."

Our Company was originally incorporated on November 15, 2000 as a Private Limited Company in the name of "Zenith Drugs Private Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Madhya Pradesh, Gwalior. Subsequently pursuant to a Special Resolution of our Shareholders passed in the Extra-Ordinary General Meeting held on September 05, 2023, our Company was converted from a Private Limited Company to Public Limited Company and consequently, the name of our Company was changed to `Zenith Drugs Limited' and a Fresh Certificate of Incorporation consequent to Conversion was issued on September 13, 2023 by the Registrar of Companies, Gwalior.MAJOR EVENTS AND MILESTONES:2000-Incorporation of the Company.2001-Started as a manufacturing house for oral and external formulations.2004-Shifted to a Schedule M GMP compliant unit.-Started the production of two lines which are liquid orals and ointments.2007-Started manufacturing ORS Powder2016-Received WHO GMP certification2019-Turnover crossed 50 Crores.2020-Turnover crossed 75 Crores.2021-Certificate of Quality Management System ISO 9001:2015 issued by Global Grading Certification-Certificate of compliance with good manufacturing practices issued by Liberia Medicines and Health Products Regulatory Authority-Our Company received subsidy under Madhya Pradesh MSME Yojna i.e. MSME Promotion Scheme,2019 as Industrial Development Grant upto 40% of the capital invested in machinery i.e. grant of ? 170.04 Lakhs2022-The Company was recognized as among top 10 MSME Pharmaceutical Manufacturers in Indore in Industry Outlook Magazine Edition.2023-Turnover crossed 100 Crores.-Collaborated with Mr. Kshatriya Valtaprasad Nandkishore for Carrying out the task of Marketing and Export of the products manufactured by Zenith.-Conversion of our Company from Private Limited Company to Public Limited Company. 2024 -"Zenith Drugs has been awarded Tenders issued by the Uttar Pradesh Medical Supplies Corporation Limited."

Parent Organisation

Zenith Drugs Ltd.

Founded

15/11/2000

Managing Director

Mr.Sandeep Bhardwaj

NSE Symbol

ZENITHDRUGSM

FAQ